Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30298 Page 1 of 18
`
`
`
`
`
`
`
`
`
`
`
`EXHIBIT 33
`
`TO DECLARATION OF CHRISTIANA GARRETT
`IN SUPPORT OF NUVASIVE, INC.’S
`REPLY IN SUPPORT OF
`MOTION FOR PARTIAL SUMMARY JUDGMENT
`AND MOTION TO EXCLUDE EXPERT OPINIONS
`(IMPLANT PATENTS)
`
`
`
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30299 Page 2 of 18
`
`
`Confidential – Outside Counsel Only
`
`NIMALKA R. WICKRAMASEKERA (SBN: 268518)
`nwickramasekera@winston.com
`DAVID P. DALKE (SBN: 218161)
`ddalke@winston.com
`WINSTON & STRAWN LLP
`333 S. Grand Avenue
`Los Angeles, CA 90071-1543
`Telephone: (213) 615-1700
`Facsimile:
`(213) 615-1750
`
`GEORGE C. LOMBARDI (Pro Hac Vice)
`glombardi@winston.com
`BRIAN J. NISBET (Pro Hac Vice)
`bnisbet@winston.com
`SARANYA RAGHAVAN (Pro Hac Vice)
`sraghavan@winston.com
`WINSTON & STRAWN LLP
`35 West Wacker Drive
`Chicago, IL 60601-9703
`Telephone: (312) 558-5600
`Facsimile: (312) 558-5700
`
`CORINNE STONE HOCKMAN (Pro Hac Vice)
`chockman@winston.com
`WINSTON & STRAWN LLP
`800 Capitol Street, Suite 2400
`Houston, TX 77002-2925
`Telephone: (713) 651-2600
`Facsimile:
`(713) 651-2700
`
`Attorneys for Defendants
`ALPHATEC HOLDINGS, INC. and ALPHATEC SPINE, INC.
`
`
`UNITED STATES DISTRICT COURT
`
`SOUTHERN DISTRICT OF CALIFORNIA – SAN DIEGO DIVISION
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`
`
`
`
`NUVASIVE, INC., a Delaware
`corporation,
`
`
`Plaintiff,
`
`v.
`
`
`ALPHATEC HOLDINGS, INC., a
`Delaware corporation and
`ALPHATEC SPINE, INC., a
`California corporation,
`
`
`Defendants.
`
`Case No. 3:18-CV-00347-CAB-MDD
`
`[Assigned to Courtroom 4C – Honorable
`Cathy Ann Bencivengo]
`
`[Magistrate: Hon. Mitchell D. Dembin]
`
`DEFENDANTS’ SUPPLEMENTAL
`RESPONSES TO PLAINTIFF
`NUVASIVE, INC.’S INTERROGATORIS
`NOS. 2, 7, 11, AND 17
`
`
`Confidential – Outside Counsel Only
`
`
`Complaint Filed: February 13, 2018
`
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF NUVASIVE, INC.’S
`INTERROGATORIES (NOS. 2, 7, AND 17)
`
`
`
`
` CASE NO. 3:18-CV-00347-CAB-MD
`
`
`EXHIBIT 33
`Page 92
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30300 Page 3 of 18
`
`
`Confidential – Outside Counsel Only
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`PROPOUNDING PARTY:
`
`PLAINTIFF NUVASIVE, INC.
`
`RESPONDING PARTY:
`
`DEFENDANTS ALPHATEC HOLDINGS, INC.
`
`INTERROGATORIES.:
`
`NOS. 2, 7, 11, AND 17
`
`AND ALPHATEC SPINE, INC.
`
`
`
`Defendants Alphatec Holdings, Inc. and Alphatec Spine, Inc. (collectively,
`
`“Alphatec” or “Defendants”) hereby provide supplemental responses to Plaintiff
`
`NuVasive, Inc.’s (“Plaintiff”) Interrogatories Nos. 2, 7, 11, and 17 as set forth in the
`
`Court’s Scheduling Order (Doc. No. 293) under Rules 26 and 33 of the Federal Rules
`
`of Civil Procedure and the applicable rules of this Court. These responses are based on
`
`information reasonably available to the Defendants, prior to completion of fact
`
`discovery and expert discovery related to the Implant Patents. The Defendants reserve
`
`the right to amend and/or supplement these responses as necessary.
`
`GENERAL OBJECTIONS
`
`The following general objections apply to each of Plaintiff’s Interrogatories and
`
`are incorporated by reference into each response made herein as though fully set forth
`
`in each and every following Interrogatory response. The assertion of the same, similar,
`
`or additional objections or the provision of partial answers in the individual responses
`
`to these Interrogatories does not waive any of Defendants’ General Objections as set
`
`forth below.
`
`1.
`
`Defendants’ responses are made solely for the purpose of the above-
`
`captioned litigation. The Defendants expressly reserve the right to object to the
`
`admissibility or otherwise seek exclusion of the information disclosed in its responses.
`
`2.
`
`Defendants have not completed their investigation, discovery or analysis
`
`of all the facts of this case and have not completed preparation for trial. Accordingly,
`
`all of the following responses are provided without prejudice to Defendants’ right to
`
`introduce at trial any evidence that is subsequently discovered relating to proof of
`
`presently known facts and to produce and introduce all evidence, whenever discovered,
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF NUVASIVE, INC.’S
`INTERROGATORIES (NOS. 2, 7, AND 17)
`
`
`
`
` CASE NO. 3:18-CV-00347-CAB-MD
`
`
`EXHIBIT 33
`Page 93
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30301 Page 4 of 18
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`Squadron retractor, Alphatec’s LLIF product offerings, LLIF interbody, and
`
`information stating that Alphatec planned to develop and release a “next generation”
`
`LLIF interbody in 2018. E.g. NUVA_ATEC0318805 at 0318823–24, 0318826,
`
`0318829; NUVA_ATEC0318771; NUVA_ATEC0318760; NUVA_ATEC0319014.
`
`NuVasive did not tell Alphatec that it believed Alphatec’s implant offerings might
`
`infringe the ’156 patent and the ’334 patent. Alphatec relied on NuVasive’s silence
`
`throughout that time period when it expended significant time and resources to launch
`
`its lateral products.
`
`
`
`NuVasive is also judicially estopped from taking positions that are contrary to
`
`prior assertions concerning its damages claims, including whether posterior fixation
`
`products are eligible for lost profits damages or irreparable harm.
`
`INTERROGATORY NO. 17:
`
`Separately and for each and every Patents-in-Suit, identify and describe in detail
`
`any past, present or prospective alternative design or alternative method that You
`
`contend to be an acceptable, non-infringing alternative to the Accused Products. Such
`
`identification and description shall include an explanation of whether such alternative
`
`design actually exists and is currently or has been used by Alphatec or others, a detailed
`
`explanation of all steps Alphatec has taken to develop any alternative design (including,
`
`but not limited to the timeline for such development, all costs and cost estimates related
`
`to such development, and the people involved in such development), an explanation of
`
`the availability of the alleged non-infringing alternative, and a detailed explanation of
`
`whether and the extent to which Alphatec has taken any steps to implement any
`
`alternative design, and to the extent Alphatec has not implemented a non-infringing
`
`alternative described in response to this Interrogatory a detailed explanation of the
`
`reasons Alphatec decided not to implement such non-infringing alternatives, including
`
`an identification of all persons with knowledge of such facts and all documents relating
`
`to the foregoing.
`
`53
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF NUVASIVE, INC.’S
`INTERROGATORIES (NOS. 2, 7, 11 AND 17)
`
`
`
`
`
` CASE NO. 3:18-CV-00347-CAB-MD
`
`
`EXHIBIT 33
`Page 94
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30302 Page 5 of 18
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`RESPONSE TO INTERROGATORY NO. 17:
`
`In addition to the General Objections, Defendants object to this Interrogatory as
`
`compound and as containing multiple discrete subparts, which in the aggregate exceed
`
`the number of interrogatories permissible under the CivLR 33.1(a). For the same
`
`reasons, this Interrogatory is unduly burdensome and overbroad. Defendants further
`
`object to this Interrogatory as overbroad, unduly burdensome, not relevant to the claims
`
`or defenses of this case, and not proportional to the needs of the case in requesting
`
`information regarding “all steps” and seeking identification of “all persons with
`
`knowledge” and “all documents relating to the foregoing.” Defendants further object
`
`to this Interrogatory as unduly burdensome because the Interrogatory requests separate
`
`identification for each patent-in-suit. Defendants further object to the extent this
`
`Interrogatory seeks information protected from discovery by the attorney-client
`
`privilege, the work product doctrine, or any other privilege or immunity. Defendants
`
`further object to this Interrogatory as seeking disclosure of private, confidential, trade
`
`secret, proprietary, or commercially and competitively sensitive information, the
`
`disclosure of which would result in substantial competitive injury to Defendants.
`
`Defendants further object to this Interrogatory as seeking to elicit premature expert
`
`discovery. Defendants further object that this Interrogatory calls for legal conclusions.
`
`Defendants object to this Interrogatory as duplicative of Interrogatory No. 7.
`
`Subject to and without waiving the foregoing General and Specific Objections,
`
`Defendants respond: Alphatec’s LLIF Squadron Retractor, Dilators, K-Wire,
`
`Intradiscal Shim and Shim Inserter Tool, Battalion Lateral Spacer, 4th Blade, and Light
`
`Cable/Light Source Connector do not infringe any valid claim of any asserted patent-
`
`in-suit. In addition to Alphatec’s products, the following products constitute non-
`
`infringing alternatives:
`
`• Medtronic retractor systems and surgical techniques, including without
`
`limitation Direct Lateral
`
`Interbody Fusion
`
`(DLIF) and MAST
`
`QUADRANT DL;
`
`54
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF NUVASIVE, INC.’S
`INTERROGATORIES (NOS. 2, 7, 11 AND 17)
`
`
`
`
`
` CASE NO. 3:18-CV-00347-CAB-MD
`
`
`EXHIBIT 33
`Page 95
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30303 Page 6 of 18
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`• TeDan Surgical Innovations retractor systems and surgical techniques,
`
`including without limitation Phantom XL3;
`
`• Synthes retractor systems and surgical techniques, including without
`
`limitation Oracle and Insight;
`
`• DePuy retractor systems and surgical techniques, including without
`
`limitation COUGAR LS Lateral Interbody Instrument System, PIPELINE
`
`LS Lateral Access System, and MIS Lateral Platform;
`
`• Globus Medical retractor systems and surgical techniques, including
`
`without
`
`limitation MARS3V, MARS3VL, MARS, MARS ACDF
`
`Cervical, and MARS Anterior;
`
`• Pioneer retractor systems and surgical techniques, including without
`
`limitation Cross-Fuse and Clarity;
`
`• K2M retractor systems and surgical techniques, including without
`
`limitation RAVINE, ALEUTIAN, SERENGETI, TERRA NOVA,
`
`CASCADIA, DENALI, and CAYMAN;
`
`• Stryker Spine retractor systems and surgical techniques, including without
`
`limitation LITe Midline Retractor System, SERENGETI, RAVINE,
`
`TERRA NOVA, and Phantom;
`
`• Zimmer Biomet retractor systems and surgical techniques; and
`
`• Alphatec’s Guided Lateral Interbody Fusion (GLIF) surgical technique.
`
`Indeed, NuVasive itself identified DLIF (Medtronic), Oracle (Synthes), Pipeline
`
`LS/Cougar (DePuy), MARS 3V/Transcontinental (Globus), Cross-Fuse (Pioneer),
`
`Ravine (K2M), and GLIF (Alphatec) as third party “lateral competition” in response to
`
`Alphatec’s Interrogatory No. 13.
`
`Alphatec incorporates by reference the Reply Declaration of Matthew Link in
`
`Support of Motion for Preliminary Injunction (Doc. No. 77-52), Alphatec’s September
`
`25, 2019 Second Amended Invalidity Contentions, Alphatec’s supplemental response
`
`to NuVasive’s Interrogatory No. 1, and the Declaration of Dr. Barton L. Sachs in
`55
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF NUVASIVE, INC.’S
`INTERROGATORIES (NOS. 2, 7, 11 AND 17)
`
`
`
` CASE NO. 3:18-CV-00347-CAB-MD
`
`
`
`
`EXHIBIT 33
`Page 96
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30304 Page 7 of 18
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`Support of Defendants’ Opposition to Motion for Preliminary Injunction (Doc. No. 49-
`
`5) in its response to this Interrogatory.
`
`SUPPLEMENTAL RESPONSE TO INTERROGATORY NO. 17:
`
`Subject to and without waiver of all previously asserted General and Specific
`
`Objections regarding this Interrogatory, Defendants supplement its previous response
`
`as follows:
`
`On January 22, 2016, Defendants received a license for U.S. Patent No.
`
`6,945,933 (issued Sept. 20, 2009) entitled “Instruments and Methods for Minimally
`
`Invasive Tissue Retraction and Surgery.”
`
`Defendants had the capabilities and the expertise to develop a two-bladed
`
`retractor pursuant to the ’933 patent that would have been acceptable to the market and
`
`would have allowed for clinically safe and reproducible lateral surgeries.
`
`Given Defendants’ capabilities and expertise, as reflected in the fact that they
`
`actually fully developed the Squadron™ retractor prior to January 2016, Alphatec
`
`would have been able to design and develop a two-bladed retractor within
`
`approximately one year with a small number of design iterations. The estimated cost
`
`for doing so is less than $200,000, which would have included engineering costs,
`
`materials, and other administrative costs.
`
`The two-bladed retractor would have been in many ways simpler than the actual
`
`design and development of the Squadron™ retractor. A two-bladed retractor is simpler
`
`to design, likely would have required fewer design iterations and less surgeon feedback
`
`than a three-bladed retractor, while still providing full functionality in order to conduct
`
`a safe and successful lateral surgery.
`
`The market’s acceptance of a two-bladed retractor is beyond dispute—there are
`
`currently several commercially successful two-bladed retractors on the market.
`
`
`
`Alphatec incorporates by reference the deposition testimonies and documents and
`
`exhibits cited therein from the following witnesses: Dr. Barton Sachs, Blake Inglish,
`
`Brad Anderson, Bryan Larsen, Carl McMillin, Dr. Charles Branch, Chris Burton, Eric
`56
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF NUVASIVE, INC.’S
`INTERROGATORIES (NOS. 2, 7, 11 AND 17)
`
`
`
` CASE NO. 3:18-CV-00347-CAB-MD
`
`
`
`
`EXHIBIT 33
`Page 97
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30305 Page 8 of 18
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`Finley, Dr. Jim Youssef, John English, Jonathan Costabile, Dr. Keith Ugone, Kelli
`
`Howell, Kevin Neels, Kyle Malone, Matthew Link, Mike Aleali, Dr. Neville Alleyne,
`
`Patrick Miles, Dr. Payam Moazzaz, Robert Judd, Rory Schermerhorn, Scott Robinson,
`
`Frank Chang, Greg Lucier.
`
`
`
`Alphatec incorporates by reference the expert reports and the documents cited
`
`therein of: Dr. Jim Youssef, Dr. Barton Sachs, Dr. Charles Branch, Blake Inglish, Dr.
`
`Keith Ugone, and Stephen Kunin.
`
`SECOND SUPPLEMENTAL RESPONSE TO INTERROGATORY NO. 17:
`
`Subject to and without waiving the foregoing General and Specific Objections,
`
`Defendants respond: Alphatec’s LLIF Battalion Lateral Spacer does not infringe any
`
`valid claim of the ’156 and ’334 patents. In addition, the following products constitute
`
`non-infringing alternatives:
`
`• Alphatec’s IdentTi™ implant;
`
`(See, e.g., https://atecspine.com/lif-identiti-lif/)
`
`• U.S. Patent No. 5,192,327 (Brantigan);
`
`• U.S. Patent No. 5,860,973 (Michelson);
`
`• U.S. Patent Application No. 2002/0165550 (Frey);
`
`• U.S. Patent App. Pub. No. 2003/0028249 (Baccelli);
`
`• J.L. Berry et al., A Morphometric Study of Human Lumbar and Selected
`
`Thoracic Vertebrae, Spine, Vol. 12, No. 4, 363 (1987);
`
`• Medtronic implants, including without limitation CLYDESDALE®
`
`Spinal System;
`
`(See,
`
`e.g.,
`
`https://www.medtronic.com/us-en/healthcare-
`
`professionals/therapies-procedures/spinal-orthopaedic/olif/indications-
`
`safety-warnings/clydesdale-spinal-system.html;
`
`http://www.thespinemarketgroup.com/wp-
`
`content/uploads/2014/09/Direct-Lateral-Surgical-Technique.pdf)
`
`• DePuy-Synthes implants, including without limitation the Oracle Cage,
`57
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF NUVASIVE, INC.’S
`INTERROGATORIES (NOS. 2, 7, 11 AND 17)
`
`
`
` CASE NO. 3:18-CV-00347-CAB-MD
`
`
`
`
`EXHIBIT 33
`Page 98
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30306 Page 9 of 18
`
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`PROTI 360°™ Ti Integrated Technology, CONCORDE Interbody System
`
`and Cougar LS Lateral Cage System;
`
`(See,
`
`e.g.,
`
`https://www.jnjmedicaldevices.com/en-US/product/proti-
`
`360degtm-ti-integrated-technology;
`
`http://www.spinaldeformity.com/Educational/Surgical%20Technique%2
`
`0Guides/Depuy/MIS%20Lateral%20Platform%20STG.pdf;
`
`http://synthes.vo.llnwd.net/o16/LLNWMB8/INT%20Mobile/Synthes%2
`
`0International/Product%20Support%20Material/legacy_Synthes_PDF/09
`
`8052-180831_LR.pdf;
`
`http://synthes.vo.llnwd.net/o16/LLNWMB8/US%20Mobile/Synthes%20
`
`North%20America/Product%20Support%20Materials/Catalogs/DSUSSP
`
`N06140231_Spine_MIS_Lateral_Platform_Product_Catalog.pdf)
`
`• Globus Medical
`
`implants,
`
`including without
`
`limitation
`
`the
`
`TransContinental® Spacer System and Caliber-L®;
`
`(See, e.g., https://www.globusmedical.com/products/transcontinental-
`
`lateral-lumbar-interbody-spacer/;
`
`https://www.globusmedical.com/expandabletechnology/caliber-l/)
`
`• Stryker Spine implants, including without limitation Cascadia;
`
`(See, e.g., https://www.stryker.com/us/en/portfolios/orthopaedics/spine--
`
`ortho-.html)
`
`• Zimmer Biomet implants, including without limitation Timberline;
`
`(See,
`
`e.g.,
`
`https://www.zimmerbiomet.com/content/dam/zimmer-
`
`biomet/medical-professionals/000-surgical-techniques/spine/timberline-
`
`lateral-fusion-system-surgical-technique.pdf;
`
`http://www.thespinemarketgroup.com/wp-
`
`content/uploads/2020/07/Timberline-Lateral.SGT-Zimmer-Biomet.pdf)
`
`• SeaSpine implants, including without limitation Regatta®; (See e.g.
`
`https://www.seaspine.com/products/regatta/)
`58
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF NUVASIVE, INC.’S
`INTERROGATORIES (NOS. 2, 7, 11 AND 17)
`
`
`
`
`
` CASE NO. 3:18-CV-00347-CAB-MD
`
`
`EXHIBIT 33
`Page 99
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30307 Page 10 of
`
`18
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`• CoreLink implants, including without limitation the CL5 LATERAL
`
`INTERBODY;
`
`(See, e.g., https://corelinksurgical.com/product/cl5-lateral/)
`
`• GSMedical implants, including without limitation the AnyPlus® Direct
`
`Lateral Interbody Fusion implant;
`
`(See, e.g., https://gsmedicalusa.com/anyplus-dlif-interbody-system/)
`
`• Neuro Structures implants, including the Pinnacle Lateral Cage; (See e.g.
`
`https://neurostructures.com/product/pinnacle-lateral/)
`
`• SpineWave implants, including without limitation the Abacus® Lateral
`
`Spacer System.
`
`(See, e.g., http://www.spinewave.com/abacus-lateral-spacer-system.html)
`
`• Surgalign implants, including without limitation the Fortilink®-L IBF
`
`System.
`
`(See, e.g., https://www.surgalign.com/product/fortilink-l-ibf-system-with-
`
`tetrafuse-3d-technology/)
`
`• Pinnacle Spine Group implants, including without limitation the InFill V2
`
`Lateral Implants.
`
`(See,
`
`e.g.,
`
`http://www.pinnaclespinegroup.com/wp-
`
`content/uploads/2016/09/PSG_InFill_Lateral_Overview_Digital_Print.pd
`
`f)
`
`• LnK implants, including without limitation the DLIF Cage System.
`
`(See,
`
`e.g.,
`
`http://www.thespinemarketgroup.com/wp-
`
`content/uploads/2014/09/LnK-Lateral-Cage-Brochure.pdf)
`
`• RTI Surgical, including without limitation the Cross-Fuse® II Lateral
`
`Fusion System.
`
`(See,
`
`e.g.,
`
`https://myspineteam.com/wp-
`
`content/uploads/2019/07/Crossfuse-ST.pdf)
`
`• OsteoMed implants, including without limitation the PrimaLIF™ LLIF
`59
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF NUVASIVE, INC.’S
`INTERROGATORIES (NOS. 2, 7, 11 AND 17)
`
`
`
` CASE NO. 3:18-CV-00347-CAB-MD
`
`
`
`
`EXHIBIT 33
`Page 100
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30308 Page 11 of
`18
`
`EXHIBIT 33
`Page 101
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30309 Page 12 of
`
`18
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`Thoracic Vertebrae, Spine, Vol. 12, No. 4, 363 (1987);
`
`• Medtronic implants, including without limitation CLYDESDALE®
`
`Spinal System;
`
`(See,
`
`e.g.,
`
`https://www.medtronic.com/us-en/healthcare-
`
`professionals/therapies-procedures/spinal-orthopaedic/olif/indications-
`
`safety-warnings/clydesdale-spinal-system.html;
`
`http://www.thespinemarketgroup.com/wp-
`
`content/uploads/2014/09/Direct-Lateral-Surgical-Technique.pdf)
`
`• DePuy-Synthes implants, including without limitation the Oracle Cage,
`
`PROTI 360°™ Ti Integrated Technology, CONCORDE Interbody System
`
`and Cougar LS Lateral Cage System;
`
`(See,
`
`e.g.,
`
`https://www.jnjmedicaldevices.com/en-US/product/proti-
`
`360degtm-ti-integrated-technology;
`
`http://www.spinaldeformity.com/Educational/Surgical%20Technique%2
`
`0Guides/Depuy/MIS%20Lateral%20Platform%20STG.pdf;
`
`http://synthes.vo.llnwd.net/o16/LLNWMB8/INT%20Mobile/Synthes%2
`
`0International/Product%20Support%20Material/legacy_Synthes_PDF/09
`
`8052-180831_LR.pdf;
`
`http://synthes.vo.llnwd.net/o16/LLNWMB8/US%20Mobile/Synthes%20
`
`North%20America/Product%20Support%20Materials/Catalogs/DSUSSP
`
`N06140231_Spine_MIS_Lateral_Platform_Product_Catalog.pdf)
`
`• Globus Medical
`
`implants,
`
`including without
`
`limitation
`
`the
`
`TransContinental® Spacer System and Caliber-L®;
`
`(See, e.g., https://www.globusmedical.com/products/transcontinental-
`
`lateral-lumbar-interbody-spacer/;
`
`https://www.globusmedical.com/expandabletechnology/caliber-l/)
`
`• Stryker Spine implants, including without limitation Cascadia;
`
`(See, e.g., https://www.stryker.com/us/en/portfolios/orthopaedics/spine--
`61
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF NUVASIVE, INC.’S
`INTERROGATORIES (NOS. 2, 7, 11 AND 17)
`
`
`
` CASE NO. 3:18-CV-00347-CAB-MD
`
`
`
`
`EXHIBIT 33
`Page 102
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30310 Page 13 of
`
`18
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`ortho-.html)
`
`• Zimmer Biomet implants, including without limitation Timberline;
`
`(See,
`
`e.g.,
`
`https://www.zimmerbiomet.com/content/dam/zimmer-
`
`biomet/medical-professionals/000-surgical-techniques/spine/timberline-
`
`lateral-fusion-system-surgical-technique.pdf;
`
`http://www.thespinemarketgroup.com/wp-
`
`content/uploads/2020/07/Timberline-Lateral.SGT-Zimmer-Biomet.pdf)
`
`• SeaSpine implants, including without limitation Regatta®; (See e.g.
`
`https://www.seaspine.com/products/regatta/)
`
`• CoreLink implants, including without limitation the CL5 LATERAL
`
`INTERBODY;
`
`(See, e.g., https://corelinksurgical.com/product/cl5-lateral/)
`
`• GSMedical implants, including without limitation the AnyPlus® Direct
`
`Lateral Interbody Fusion implant;
`
`(See, e.g., https://gsmedicalusa.com/anyplus-dlif-interbody-system/)
`
`• Neuro Structures implants, including the Pinnacle Lateral Cage; (See e.g.
`
`https://neurostructures.com/product/pinnacle-lateral/)
`
`• SpineWave implants, including without limitation the Abacus® Lateral
`
`Spacer System.
`
`(See, e.g., http://www.spinewave.com/abacus-lateral-spacer-system.html)
`
`• Surgalign implants, including without limitation the Fortilink®-L IBF
`
`System.
`
`(See, e.g., https://www.surgalign.com/product/fortilink-l-ibf-system-with-
`
`tetrafuse-3d-technology/)
`
`• Pinnacle Spine Group implants, including without limitation the InFill V2
`
`Lateral Implants.
`
`(See,
`
`e.g.,
`
`http://www.pinnaclespinegroup.com/wp-
`
`content/uploads/2016/09/PSG_InFill_Lateral_Overview_Digital_Print.pd
`62
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF NUVASIVE, INC.’S
`INTERROGATORIES (NOS. 2, 7, 11 AND 17)
`
`
`
` CASE NO. 3:18-CV-00347-CAB-MD
`
`
`
`
`EXHIBIT 33
`Page 103
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30311 Page 14 of
`
`18
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`f)
`
`• LnK implants, including without limitation the DLIF Cage System.
`
`(See,
`
`e.g.,
`
`http://www.thespinemarketgroup.com/wp-
`
`content/uploads/2014/09/LnK-Lateral-Cage-Brochure.pdf)
`
`• RTI Surgical, including without limitation the Cross-Fuse® II Lateral
`
`Fusion System.
`
`(See,
`
`e.g.,
`
`https://myspineteam.com/wp-
`
`content/uploads/2019/07/Crossfuse-ST.pdf)
`
`• OsteoMed implants, including without limitation the PrimaLIF™ LLIF
`
`Unitary PEEK Implant.
`
`(See,
`
`e.g.,
`
`http://www.thespinemarketgroup.com/wp-
`
`content/uploads/2014/02/OsteoMed-primaLIF-Surgical.pdf)
`
`• Astura Medical implants, including without limitation the Sirion Lateral
`
`Lumbar Interbody Spacers.
`
`(See, e.g., https://asturamedical.com/product/sirion-llif-system/)
`
`• Life Spine implants, including without limitation the PLATEAU®-X
`
`spacer system.
`
`(See, e.g., https://lifespine.com/plateau-x/)
`
`• AltusSpine, including without limitation the Imola Lateral IBF System;
`
`(See,
`
`e.g.,
`
`http://www.thespinemarketgroup.com/wp-
`
`content/uploads/2013/06/Imola-Lateral-IBF-System-Surgical-
`
`Technique.pdf)
`
`• ChoiceSpine implants, including without limitation the VEO® Lateral
`
`System.
`
`(See, e.g., https://choicespine.com/products/lateral-system/veo/)
`
`Alphatec also incorporates by reference its response to Interrogatory No. 7.
`
`
`
`
`
`63
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF NUVASIVE, INC.’S
`INTERROGATORIES (NOS. 2, 7, 11 AND 17)
`
`
`
`
`
` CASE NO. 3:18-CV-00347-CAB-MD
`
`
`EXHIBIT 33
`Page 104
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30312 Page 15 of
`
`18
`
`
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`Dated: November 6, 2020
`
`WINSTON & STRAWN LLP
`
`
`
`By: /s/ Nimalka R. Wickramasekera
`NIMALKA R. WICKRAMASEKERA
`GEORGE C. LOMBARDI
`BRIAN J. NISBET
`DAVID P. DALKE
`SARANYA RAGHAVAN
`CORINNE STONE HOCKMAN
`
`Attorneys for Defendants
`ALPHATEC HOLDINGS, INC. AND
`ALPHATEC SPINE, INC.
`
`64
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF NUVASIVE, INC.’S
`INTERROGATORIES (NOS. 2, 7, 11 AND 17)
`
`
`
`
`
` CASE NO. 3:18-CV-00347-CAB-MD
`
`
`EXHIBIT 33
`Page 105
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30313 Page 16 of
`
`
`18
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`CERTIFICATE OF SERVICE
`
`United States District Court for the Southern District of California
`
`Case No. 3:18-CV-00347-CAB-MDD
`
`I, Lev Tsukerman, certify and declare as follows:
`
`I am over the age of 18 years and not a party to this action. My business address
`
`is 333 South Grand Avenue, 38th Floor, Los Angeles, California 90071. On November
`
`6, 2020, I served the following document:
`
`DEFENDANTS’ SUPPLEMENTAL RESPONSES TO PLAINTIFF
`NUVASIVE, INC.’S INTERROGATORIS NOS. 2, 7, 11, AND 17
`
`
`
`
`by electronically transmitting copy(ies) of the document(s) listed above via
`email to the addressees as set forth below, in accordance with the parties’
`agreement to be served electronically pursuant to Fed. R. Civ. P. 5, or
`Local Rule of Court, or court order. No error messages were received after
`said transmission.
`
`
`
`SEE ATTACHED SERVICE LIST
`
`
`
`I declare under penalty of perjury under the laws of the State of California and
`
`the United States that the foregoing is true and correct.
`
`Executed on November 6, 2020 at Los Angeles, California.
`
`
`By: /s/ Lev Tsukerman
`Lev Tsukerman
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`
`
`CASE NO. 3:18-CV-00347-CAB-MDD
`
`EXHIBIT 33
`Page 106
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30314 Page 17 of
`
`
`18
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`SERVICE LIST
`
`
`Paul D. Tripodi II, Esq.
`Erik Carlson
`Christiana Garrett
`Rhyea Malik
`Wilson Sonsini Goodrich & Rosati P.C.
`633 West Fifth Street, Suite 1550
`Los Angeles, CA 90071
`Telephone: (323) 210-2900
`Facsimile: (866) 974-7329
`Email: ptripodi@wsgr.com
`Email: ecarlson@wsgr.com
`Email: cgarrett@wsgr.com
`Email: rmalik@wsgr.com
`Email: nuva/atec@wsgr.com
`Email: NUVA_ATEC-IP@list.wsgr.com
`
`Wendy L. Devine, Esq.
`Wilson Sonsini Goodrich & Rosati P.C.
`One Market Plaza
`Spear Tower, Suite 3300
`San Francisco, CA 94105
`Telephone: (415) 947-2000
`Facsimile: (415) 947-2099
`Email: wdevine@wsgr.com
`
`Natalie J. Morgan, Esq.
`Christina Elizabeth Dashe, Esq.
`Wilson Sonsini Goodrich & Rosati P.C.
`12235 El Camino Real, Suite 200
`San Diego, CA 92130
`Telephone: (858) 350-2363
`Facsimile: (858) 350-2399
`Email: nmorgan@wsgr.com
`Email: cdashe@wsgr.com
`
`Sara L. Tolbert, Esq.
`Wilson Sonsini Goodrich & Rosati P.C.
`650 Page Mill Road
`Palo Alto, CA 94304
`Telephone: (650) 493-9300
`Facsimile: (650) 565-5100
`Email: stolbert@wsgr.com
`
`Hilgers Graben PLLC
`NuVa-HG@hilgersgraben.com
`Michael T. Hilgers (Pro Hac Vice)
`mhilgers@hilgersgraben.com
`J. Bub Windle (Pro Hac Vice)
`bwindle@hilgersgraben.com
`Trenton T. Tanner (Pro Hac Vice)
`ttanner@hilgersgraben.com
`575 Fallbrook Blvd, Suite 202
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`
`
`CASE NO. 3:18-CV-00347-CAB-MDD
`
`EXHIBIT 33
`Page 107
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 311-9 Filed 02/26/21 PageID.30315 Page 18 of
`
`
`18
`
`Lincoln, NE 68521
`Telephone: 402-260-2106
`Fax: 402-413-1880
`
`Andrew R. Graben (Pro Hac Vice)
`agraben@hilgersgraben.com
`10000 N. Central Expy, Suite 400
`Dallas, TX 75231
`Telephone: 214-842-6828
`Fax: 402-413-1880
`
`Attorneys for Plaintiff NuVasive, Inc.
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`26
`
`27
`
`28
`
`CERTIFICATE OF SERVICE
`
`
`
`
`
`
`
`CASE NO. 3:18-CV-00347-CAB-MDD
`
`EXHIBIT 33
`Page 108
`
`